title: Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.
authors.affiliation: Dept. of Pediatrics, Free University of Berlin, FRG.
authors.forename: G
authors.initials: G
authors.lastname: Henze
authors.forename: R
authors.initials: R
authors.lastname: Fengler
authors.forename: A
authors.initials: A
authors.lastname: Reiter
authors.forename: J
authors.initials: J
authors.lastname: Ritter
authors.forename: H
authors.initials: H
authors.lastname: Riehm
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005860:Germany, West / Q000453:epidemiology; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D015993:Life Tables; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D011239:Prednisolone / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D015996:Survival Rate; D013866:Thioguanine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D001215:Asparaginase; D013866:Thioguanine; D002955:Leucovorin; D008727:Methotrexate; D003630:Daunorubicin